Ning Ren

4.8k total citations
113 papers, 3.7k citations indexed

About

Ning Ren is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ning Ren has authored 113 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 43 papers in Cancer Research and 38 papers in Oncology. Recurrent topics in Ning Ren's work include Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Cancer, Hypoxia, and Metabolism (13 papers) and Pancreatic and Hepatic Oncology Research (11 papers). Ning Ren is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Cancer, Hypoxia, and Metabolism (13 papers) and Pancreatic and Hepatic Oncology Research (11 papers). Ning Ren collaborates with scholars based in China, United States and Ethiopia. Ning Ren's co-authors include Lun–Xiu Qin, Qiongzhu Dong, Qing‐Hai Ye, Hu‐Liang Jia, Chenhao Zhou, Haijun Zhou, Hui‐Chuan Sun, Manar Atyah, Jia Fan and Zhao–You Tang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ning Ren

111 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ning Ren China	36	1.8k	1.5k	985	707	594	113	3.7k
Wen‐Ming Cong China	34	1.4k 0.8×	1.1k 0.7×	773 0.8×	1.2k 1.7×	473 0.8×	135	3.4k
Cédric Coulouarn France	30	1.7k 1.0×	1.2k 0.8×	862 0.9×	698 1.0×	247 0.4×	72	3.2k
Jun Akiba Japan	40	1.3k 0.7×	929 0.6×	1.7k 1.8×	781 1.1×	963 1.6×	309	5.5k
Koichi Kawamoto Japan	35	2.3k 1.3×	1.7k 1.2×	1.4k 1.4×	373 0.5×	406 0.7×	164	4.2k
Rishu Takimoto Japan	40	2.6k 1.5×	564 0.4×	1.6k 1.6×	755 1.1×	503 0.8×	155	5.8k
Runqiu Jiang China	33	2.3k 1.3×	1.7k 1.2×	1.0k 1.0×	500 0.7×	264 0.4×	61	4.3k
Zhi Dai China	38	2.7k 1.5×	1.9k 1.3×	1.7k 1.7×	677 1.0×	605 1.0×	97	5.4k
Sandra Rebouissou France	28	2.5k 1.4×	1.6k 1.1×	1.0k 1.0×	1.8k 2.5×	613 1.0×	40	5.0k
Xiao‐Dong Zhu China	38	1.8k 1.0×	1.3k 0.9×	1.5k 1.5×	1.2k 1.6×	536 0.9×	112	4.3k
Antonio Mazzocca Italy	30	1.4k 0.8×	691 0.5×	815 0.8×	768 1.1×	214 0.4×	86	3.0k

Countries citing papers authored by Ning Ren

Since Specialization

Citations

This map shows the geographic impact of Ning Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Ren more than expected).

Fields of papers citing papers by Ning Ren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ning Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Ren. The network helps show where Ning Ren may publish in the future.

Co-authorship network of co-authors of Ning Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Ning Ren. A scholar is included among the top collaborators of Ning Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ning Ren. Ning Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Min, Xiangyu Gao, Shuang‐Jian Qiu, et al.. (2025). The Role of Post-Translational Modifications in Necroptosis. Biomolecules. 15(4). 549–549. 1 indexed citations

Xu, Min, Peiyi Xie, Shaoqing Liu, et al.. (2025). LCAT deficiency promotes hepatocellular carcinoma progression and lenvatinib resistance by promoting triglyceride catabolism and fatty acid oxidation. Cancer Letters. 612. 217469–217469. 5 indexed citations

Xu, Wenxin, Jun Cao, Pei Wang, et al.. (2024). Deubiquitination of CIB1 by USP14 promotes lenvatinib resistance via the PAK1-ERK1/2 axis in hepatocellular carcinoma. International Journal of Biological Sciences. 20(9). 3269–3284. 3 indexed citations

Huang, Xiaoyong, Qiang Gao, Fei Liang, et al.. (2024). Two stage, multi-center trial of cadonilimab and LM-302 for patients with CLDN18.2+ biliary tract cancer (BTC) that failed chemotherapy and PD-(L)1 antibody (ZSAB-Calm).. Journal of Clinical Oncology. 42(16_suppl). e16152–e16152. 2 indexed citations

He, Yu‐Ping, Minghao Xu, Chenhao Zhou, et al.. (2024). The Prognostic Significance of CTSV Expression in Patients with Hepatocellular Carcinoma. International Journal of General Medicine. Volume 17. 4867–4881. 3 indexed citations

Weng, Jialei, Zheng Wang, Zhiqiu Hu, et al.. (2024). Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy. Cancer Research. 84(11). 1817–1833. 18 indexed citations

Wei, Yuanyan, Qihang Chen, Chenhao Zhou, et al.. (2023). Loss of α-1,2-mannosidase MAN1C1 promotes tumorigenesis of intrahepatic cholangiocarcinoma through enhancing CD133-FIP200 interaction. Cell Reports. 42(12). 113588–113588. 6 indexed citations

Li, Qingli, Chenhao Zhou, Zhiqiu Hu, et al.. (2023). Hepatocellular carcinoma histopathological images grading with a novel attention-sharing hybrid network based on multi-feature fusion. Biomedical Signal Processing and Control. 86. 105126–105126. 8 indexed citations

Weng, Jialei, Shaoqing Liu, Qiang Zhou, et al.. (2023). Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 11(6). e006655–e006655. 32 indexed citations

10.

Zhou, Chenhao, Jialei Weng, Chunxiao Liu, et al.. (2023). Disruption of SLFN11 Deficiency–Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti–PD-1 Therapy Efficacy in Hepatocellular Carcinoma. Gastroenterology. 164(7). 1261–1278. 76 indexed citations

11.

Atyah, Manar, Chenhao Zhou, Qiang Zhou, et al.. (2022). The Age-Specific Features and Clinical Significance of NRF2 and MAPK10 Expression in HCC Patients. SHILAP Revista de lepidopterología. 7 indexed citations

12.

Ma, Xiaolu, Keyu Zhu, Suhong Xie, et al.. (2022). Identification of a novel Calpain-2-SRC feed-back loop as necessity for β-Catenin accumulation and signaling activation in hepatocellular carcinoma. Oncogene. 41(27). 3554–3569. 11 indexed citations

13.

Hu, Zhiqiang, Shao‐Lai Zhou, Songyang Yu, et al.. (2021). The spatial distribution of immune cell subpopulations in hepatocellular carcinoma. Cancer Science. 113(2). 423–431. 17 indexed citations

14.

Wu, Xiaolin, Jiahui Li, Asmae Gassa, et al.. (2020). Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma. International Journal of Biological Sciences. 16(9). 1551–1562. 105 indexed citations

15.

Zhu, Wenwei, Lei Guo, Hu‐Liang Jia, et al.. (2013). Evaluation of Midkine as a Diagnostic Serum Biomarker in Hepatocellular Carcinoma. Clinical Cancer Research. 19(14). 3944–3954. 111 indexed citations

16.

Dong, Qiongzhu, Yue Zhao, Hu‐Liang Jia, et al.. (2012). Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma. Hepatology. 57(3). 1024–1034. 55 indexed citations

17.

Ren, Ning, Jincai Wu, Qiongzhu Dong, et al.. (2011). Association of Specific Genotypes in Metastatic Suppressor HTPAP with Tumor Metastasis and Clinical Prognosis in Hepatocellular Carcinoma. Cancer Research. 71(9). 3278–3286. 17 indexed citations

18.

Sun, Jian, Haijun Zhou, Qiongzhu Dong, et al.. (2009). The prognostic significance of preoperative plasma levels of osteopontin in patients with TNM stage-I of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 136(1). 1–7. 35 indexed citations

19.

Zhang, Hui, Qing‐Hai Ye, Ning Ren, et al.. (2006). The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 132(11). 709–717. 72 indexed citations

20.

Ren, Ning, et al.. (2002). Platelets promote the adhesion of human hepatoma cells with a highly metastatic potential to extracellular matrix protein: involvement of platelet P-selectin and GP IIb-IIIa. Journal of Cancer Research and Clinical Oncology. 128(5). 283–287. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact